NIDC News

Our NIDC News reports the latest developments in U.S. Department of Energy’s isotope production efforts, university partnerships, facility improvements, staff news, and other notable center activities as they occur. Stay Connected

 

Srivastava award
Suresh Srivastava, a Senior Medical Scientist Emeritus and research advisor in the Collider-Accelerator Department and Medical Isotope Research & Production Program at Brookhaven National Laboratory (BNL), is this year’s recipient of the Glenn T. Seaborg Award. He recently accepted the award during the American Chemical Society’s (ACS) Spring 2018 National Meeting & Exposition in New…
NIDC thumbnail
Subject to the availability of funds, the U.S. Department of Energy Isotope Program (DOE IP) considers a limited number of proposals to offer travel bursaries for students and postdoctoral trainees to attend domestic and international conferences, meetings, or workshops. All proposals are competitively reviewed, and selections are made based on numerous criteria that align with the DOE IP mission…
NIDC thumbnail
The DOE Isotope Program (DOE IP) will host three user group meetings during the upcoming Annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Philadelphia, PA. These meetings are being organized by the DOE IP to encourage free discussion and collaboration by users of specific isotopes as well as to provide information on the broader DOE IP portfolio. Details on each…
NIDC
The U.S. Department of Energy’s Isotope Program has posted a new Funding Opportunity Announcement (FOA) for Research, Development and Training in Isotope Production (DE-FOA-0001896). This FOA can be found online at the U.S. Department of Energy’s Office of Science website, or at http://science.energy.gov/np/funding-opportunities/. Eligibility for the FOA is limited to domestic institutions of…
NIDC
A MESSAGE FROM THE DIRECTOR OF THE U.S. DEPARTMENT OF ENERGY ISOTOPE PROGRAM Hello everyone, I would like to announce that the Department of Energy (DOE) Program Manager for Isotope Facilities, Dr. Ethan Balkin, has expressed interest in assuming the responsibilities of Program Manager for Isotope R&D. This was the position vacated by Dr. Dennis Phillips when he retired last year. So please…
Ru-96
The US Department of Energy Isotope Program (DOE IP) recently provided more than 500 mg of highly enriched ruthenium-96 (Ru-96), most of which was newly produced at Oak Ridge National Laboratory’s Enriched Stable Isotope Pilot Plant (ESIPP). This marks the first production of a newly enriched stable isotope by the DOE IP in nearly 20 years. In addition, this milestone successfully fulfills a…
PNNL publication
An automated purification of zirconium-89 (89Zr) from a yttrium (Y) target has been developed by researchers at the Pacific Northwest National Laboratory (PNNL), in collaboration with the University of Washington Department of Radiology, and is detailed in the February 2018 issue of Applied Radiation and Isotopes. A positron emitter with a relatively long half-life (78.4 h), 89Zr is a promising…
NIDC
Actinium-225 (Ac-225, t1/2 = 10.0 days) is routinely available from the U.S. Department of Energy’s Isotope Program. Starting in February 2018, Ac-225 will be produced regularly via the proton bombardment of thorium-232 (Th-232) targets at our accelerator sites at Brookhaven (BNL) and Los Alamos National Laboratories (LANL). Ac-225 continues to be distributed as a thorium-229 (Th-229) decay…
image
The latest issue of our National Isotope Development Center (NIDC) Newsletter is now available! Read about the latest developments in the U.S. Department of Energy’s (DOE) isotope production, university partnerships, facility improvements, staff news, and more. Highlights for this issue include:  New University Partnership with University of Missouri Fortifies Supply of High Specific Activity Se…
UM logo
The U.S. Department of Energy Isotope Program is pleased to announce the availability of lutetium-177 (Lu-177) for distribution through our partnership with the University of Missouri Research Reactor Center (MURR). Lu-177 is a radioisotope commonly used for research in cancer treatment and has a half-live of 6.65 days. The product, Lu-177 chloride solution (0.05M HCl), has a specific activity of…